Ozempic has a list price of $1,027.51 per pen, regardless of dose. That’s the manufacturer’s price before any insurance discounts or rebates, and it represents roughly a month’s supply. What you actually pay depends heavily on whether you have insurance, what type of coverage you carry, and whether you qualify for any savings programs.
The List Price vs. What You Actually Pay
Novo Nordisk sets the wholesale acquisition cost for every Ozempic pen at $1,027.51, whether you’re on the 0.25 mg starter dose, the 0.5 mg, 1 mg, or 2 mg maintenance dose. This is the price wholesalers and pharmacies pay before negotiating their own discounts. At the pharmacy counter, the average cash price (without insurance) runs closer to $1,396 for a single pen, since pharmacies add their own markup.
For context, that price is dramatically higher than what patients in other countries pay. A month’s supply of Ozempic 1 mg costs about $147 in Canada. The U.S. price is roughly seven to nine times higher for the identical medication.
What Insurance Typically Covers
Most commercial insurance plans cover Ozempic for type 2 diabetes, but they almost always require prior authorization. Your doctor will need to demonstrate that you meet specific clinical criteria before coverage kicks in. Using Aetna’s policy as a representative example, insurers generally require at least one of the following: that you’ve tried and failed on a first-line diabetes medication like metformin, that your blood sugar levels remain elevated (an A1C of 7.5% or higher) despite other treatments, or that you have established cardiovascular disease or advanced kidney disease.
If your insurer approves coverage, your out-of-pocket cost drops to your plan’s specialty drug copay or coinsurance, which varies widely. Some patients pay $25 to $50 per month, while others on high-deductible plans may owe several hundred dollars until they hit their deductible. Your specific plan tier for Ozempic makes a big difference, so check your formulary or call your insurer before filling the prescription.
One important limitation: insurers cover Ozempic only for its FDA-approved indication, which is type 2 diabetes. If you’re seeking it purely for weight loss without a diabetes diagnosis, most plans will deny coverage. Wegovy, which contains the same active ingredient at a higher dose, is the version approved for weight management.
The Manufacturer Savings Card
Novo Nordisk offers a co-pay savings card that can bring your monthly cost down to as little as $25 per fill. The card provides up to $100 in savings per month and remains valid for up to 48 months. There are two key restrictions: you need existing commercial insurance that already covers Ozempic, and you cannot be enrolled in any government insurance program. Medicare, Medicaid, Tricare, and VA beneficiaries are all excluded from the savings card.
Medicare Coverage and Upcoming Changes
Medicare Part D plans generally cover Ozempic for type 2 diabetes, though copays in the coverage gap (the “donut hole”) can still be significant. What Medicare does not currently cover is semaglutide prescribed for weight loss.
That’s changing partially in 2026. CMS announced the Medicare GLP-1 Bridge program, which will run from July 2026 through December 2027 and provide Medicare beneficiaries access to certain weight loss medications. However, Ozempic is not on the list of eligible drugs for this bridge program. The covered medications are Wegovy, Zepbound, and Foundayo, all of which are specifically approved for weight management.
A bigger pricing shift is on the horizon. Ozempic was selected for Medicare drug price negotiations under the Inflation Reduction Act. Those negotiations are taking place in 2025, and the resulting lower prices will take effect in 2027. The exact negotiated price hasn’t been announced yet, but the first round of negotiations on other drugs produced discounts of 38% to 79% off list prices, so the reduction could be substantial for Medicare beneficiaries.
Patient Assistance for Uninsured or Low-Income Patients
If you’re uninsured or underinsured, Novo Nordisk runs a patient assistance program through NovoCare that can provide Ozempic at no cost. To qualify, you need to be a U.S. citizen or legal resident with a total household income at or below 400% of the federal poverty level. For a single person in 2024, that threshold was roughly $60,000 per year. You apply through NovoCare.com, and your prescribing provider will need to be involved in the process.
Compounded Semaglutide as a Lower-Cost Option
Compounded versions of semaglutide, the active ingredient in Ozempic, have become widely available through telehealth platforms and compounding pharmacies. These typically cost between $129 and $497 per month, a fraction of the brand-name price. That range usually reflects just the medication cost. Many providers tack on additional fees for the initial consultation, ongoing prescriber visits, and required lab work, so the true monthly expense can be higher than advertised.
There’s an important tradeoff: compounded semaglutide is not FDA-approved. These formulations are mixed by compounding pharmacies rather than manufactured under the same standardized process as brand-name Ozempic. The FDA has raised concerns about the quality and consistency of some compounded products. If you go this route, look for pharmacies that are accredited and registered with the FDA, and understand that the potency and purity of each batch may vary.
Comparing Your Realistic Options
- Commercial insurance with savings card: As low as $25 per month
- Commercial insurance without savings card: $25 to $300+ per month depending on your plan
- Medicare Part D (for diabetes): Varies by plan, with negotiated pricing expected in 2027
- Patient assistance program: Free if you qualify based on income
- Cash price at pharmacy: Approximately $1,000 to $1,400 per month
- Compounded semaglutide: $129 to $497 per month, plus possible provider fees
Your first step is checking whether your insurance covers Ozempic and at what tier. If you have commercial coverage, the manufacturer savings card is the simplest way to reduce your copay. If you’re uninsured and your income qualifies, the patient assistance program is worth pursuing before paying out of pocket or turning to compounded alternatives.